Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v12-EN | Version v9-FR | |
---|---|---|
Language | English | French |
Date Updated | 2019-07-04 | 2019-06-20 |
Drug Identification Number | 02462680 | 02462680 |
Brand name | TEPADINA | TEPADINA |
Common or Proper name | Thiotepa for Injection | Thiotepa for Injection |
Company Name | ADIENNE SA | ADIENNE SA |
Ingredients | THIOTEPA | THIOTEPA |
Strength(s) | 15MG | 15MG |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 1 vial | 1 vial |
ATC code | L01AC | L01AC |
ATC description | ||
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2019-07-11 | 2019-06-27 |
Actual start date | ||
Estimated end date | 2019-07-30 | 2019-07-30 |
Actual end date | ||
Shortage status | Anticipated shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | TEPADINA 100mg (DIN 02462702) is available. For more information please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149 Please also contact ADIENNE at med-info@adienne.com for further information | TEPADINA 100mg (DIN 02462702) is available. For more information please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149 Please also contact ADIENNE at med-info@adienne.com for further information |
Health Canada comments |